Tuberculosis and non-communicable disease multimorbidity : an analysis of the World Health Survey in 48 low- and middle-income countries by Stubbs, Brendon et al.
This is a repository copy of Tuberculosis and non-communicable disease multimorbidity : 
an analysis of the World Health Survey in 48 low- and middle-income countries.




Stubbs, Brendon, Siddiqi, Kamran orcid.org/0000-0003-1529-7778, Elsey, Helen 
orcid.org/0000-0003-4724-0581 et al. (5 more authors) (2021) Tuberculosis and non-
communicable disease multimorbidity : an analysis of the World Health Survey in 48 low- 
and middle-income countries. International Journal of Environmental Research and Public 





This article is distributed under the terms of the Creative Commons Attribution (CC BY) licence. This licence 
allows you to distribute, remix, tweak, and build upon the work, even commercially, as long as you credit the 
authors for the original work. More information and the full terms of the licence here: 
https://creativecommons.org/licenses/ 
Takedown 
If you consider content in White Rose Research Online to be in breach of UK law, please notify us by 
emailing eprints@whiterose.ac.uk including the URL of the record and the reason for the withdrawal request. 




Tuberculosis and Non-Communicable Disease Multimorbidity:
An Analysis of the World Health Survey in 48 Low- and
Middle-Income Countries
Brendon Stubbs 1,2,*, Kamran Siddiqi 3,4, Helen Elsey 3,4, Najma Siddiqi 3,4 , Ruimin Ma 2 , Eugenia Romano 2,
Sameen Siddiqi 5 and Ai Koyanagi 6,7


Citation: Stubbs, B.; Siddiqi, K.;
Elsey, H.; Siddiqi, N.; Ma, R.; Romano,
E.; Siddiqi, S.; Koyanagi, A.
Tuberculosis and Non-Communicable
Disease Multimorbidity: An Analysis
of the World Health Survey in 48
Low- and Middle-Income Countries.
Int. J. Environ. Res. Public Health 2021,
18, 2439. https://doi.org/
10.3390/ijerph18052439
Academic Editor: Paul Tchounwou
Received: 18 January 2021
Accepted: 26 February 2021
Published: 2 March 2021
Publisher’s Note: MDPI stays neutral
with regard to jurisdictional claims in
published maps and institutional affil-
iations.
Copyright: © 2021 by the authors.
Licensee MDPI, Basel, Switzerland.
This article is an open access article
distributed under the terms and
conditions of the Creative Commons
Attribution (CC BY) license (https://
creativecommons.org/licenses/by/
4.0/).
1 Physiotherapy Department, South London and Maudsley NHS Foundation Trust, Denmark Hill,
London SE5 8AZ, UK
2 Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience (IoPPN), King’s
College London, London SE5 8AB, UK; ruimin.1.ma@kcl.ac.uk (R.M.); eugenia.romano@kcl.ac.uk (E.R.)
3 Department of Health Sciences, The University of York, York YO10 5DD, UK;
kamran.siddiqi@york.ac.uk (K.S.); helen.elsey@york.ac.uk (H.E.); najma.siddiqi@york.ac.uk (N.S.)
4 Hull York Medical School, The University of York, York YO10 5DD, UK
5 Department of Community Health Sciences, Aga Khan University, Karachi 74800, Pakistan;
sameen.siddiqi@aku.edu
6 Research and Development Unit, Parc Sanitari Sant Joan de Déu, CIBERSAM, 08830 Barcelona, Spain;
a.koyanagi@pssjd.org
7 ICREA, Pg. Lluis Companys 23, 08010 Barcelona, Spain
* Correspondence: brendon.stubbs@kcl.ac.uk
Abstract: Tuberculosis (TB) is a leading cause of mortality in low- and middle-income countries
(LMICs). TB multimorbidity [TB and ≥1 non-communicable diseases (NCDs)] is common, but
studies are sparse. Cross-sectional, community-based data including adults from 21 low-income
countries and 27 middle-income countries were utilized from the World Health Survey. Associations
between 9 NCDs and TB were assessed with multivariable logistic regression analysis. Years lived
with disability (YLDs) were calculated using disability weights provided by the 2017 Global Burden
of Disease Study. Eight out of 9 NCDs (all except visual impairment) were associated with TB (odds
ratio (OR) ranging from 1.38–4.0). Prevalence of self-reported TB increased linearly with increasing
numbers of NCDs. Compared to those with no NCDs, those who had 1, 2, 3, 4, and ≥5 NCDs had 2.61
(95% confidence interval (CI) = 2.14–3.22), 4.71 (95%CI = 3.67–6.11), 6.96 (95%CI = 4.95–9.87), 10.59
(95%CI = 7.10–15.80), and 19.89 (95%CI = 11.13–35.52) times higher odds for TB. Among those with
TB, the most prevalent combinations of NCDs were angina and depression, followed by angina and
arthritis. For people with TB, the YLDs were three times higher than in people without multimorbidity
or TB, and a third of the YLDs were attributable to NCDs. Urgent research to understand, prevent
and manage NCDs in people with TB in LMICs is needed.
Keywords: tuberculosis; non-communicable diseases; comorbidities; low- and middle-income coun-
tries; multimorbidity
1. Introduction
Tuberculosis (TB) is the leading cause of deaths from a single infectious disease
globally [1]. There were approximately 10 million TB cases worldwide, and 1.5 million
people died from TB in 2018 [1]. People from low- and middle-income countries (LMICs)
are at a high risk of developing TB [2,3], with over 95% of TB cases and deaths occurring
in LMICs [1]. Significant factors associated with increased risk of TB have been widely
reported, including malnutrition, diabetes [4], poverty, overcrowding [5], alcoholism,
smoking [6], human immunodeficiency virus (HIV) and chronic pulmonary disease [7].
As a long-term infectious disease, TB may lead to the breakdown of immune surveil-
lance [7], increasing one’s susceptibility to other conditions such as non-communicable
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diseases (NCDs) [6,8] (e.g., cancer, diabetes, respiratory and cardiovascular diseases), which
together contribute to two thirds of the global mortality [9]. Moreover, there is evidence
of an increased prevalence of mental health problems in those diagnosed with TB [10,11].
The relationship between TB and chronic physical conditions may be bidirectional. Several
health conditions, such as diabetes [12–14] and chronic lung diseases including chronic
obstructive pulmonary disease and silicosis [6], have been previously reported as important
risk factors for TB.
The co-occurrence of two or more chronic diseases in one individual at one point of
his/her life is typically referred to as multimorbidity [15,16]. Multimorbidity is becoming a
primary concern in our global healthcare system, especially for LMICs where there is a need
to consider economic restraints when planning levels of care [17]. There is evidence that
multimorbidity may occur in 1 out of 4 adults across LMICs [18], and that its prevalence
may be increasing due to increasing life expectancy in these settings [19]. The determinants
of multimorbidity include socioeconomic factors (e.g., unemployment, deprivation level,
economic restrains), low accessibility to healthcare [20], and health risk behaviors (e.g., low
physical activity, poor diet) [21,22]. All these determinants are very evident and alarming
in LMICs [23].
In countries where TB is endemic [1], a concerning rapid increase in NCDs has been
reported, especially in sub-Saharan Africa [3,24] and in South Asian regions [25], and partic-
ularly for those NCDs associated with TB. Despite this, evidence on NCD multimorbidity
in people with TB in these areas remains scarce, with numerous gaps and limitations in the
literature. First, most research considering TB multimorbidity—presence of TB alongside
one or more chronic conditions—has included small-scale studies [26], been restricted
to a single country [4,27,28], or only considered one comorbid chronic condition [29,30].
Second, limited information is available on the actual patterns and risks of multimorbidity
compared to the general population and on the burden of disease associated with TB
multimorbidity [31]. Nonetheless, some preliminary research has suggested that TB multi-
morbidity is associated with increased use of healthcare services [32,33], increased symptom
complexity [34], high premature mortality risk [35,36], increased disabilities [37,38], poor
quality of life [38–40], frequent hospitalization [41,42], and high healthcare expenses [6].
Despite the negative consequences associated with TB multimorbidity, TB services tend to
be single focus programs that rarely screen for NCDs, and NCD care itself is also limited
and rarely provided, especially in LMICs. Therefore, given the aforementioned knowledge
gap, the aim of this study was to utilize a large multinational cross-sectional study to assess
the pattern and burden of multimorbidity in adults with TB and NCDs across 48 LMICs.
2. Materials and Methods
2.1. The Survey
The World Health Survey (WHS) was a cross-sectional survey carried out in 70 coun-
tries in 2002–2004 (data freely available for analysis). Survey details are available else-
where [43]. Briefly, single-stage random sampling and stratified multi-stage random cluster
sampling was conducted in 10 and 60 countries, respectively. Eligible participants were
those with a valid home address and aged ≥18 years. One individual was randomly
chosen from each household with the use of Kish Grid tables [44]. The questionnaire was
subject to standard translation procedures to ensure comparability between countries. The
questionnaire was administered face-to-face by trained interviewers. The overall individual
response rate was 98.5% [45]. To adjust for non-response, sampling weights were generated
using the population distribution as reported by the United Nations Statistical Division [46].
Ethical approval for the survey was provided by ethical boards at each study site. All
participants gave their informed consent.
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2.2. Variables
2.2.1. Tuberculosis
TB case definition was based on self-reported symptoms of active disease in the past
12 months. The survey procedures did not include mycobacterial culture or sputum smear
examinations. Specifically, as in previous WHS publications [11,47–49], those who had both
(a) a cough that lasted for three weeks or longer, and (b) blood in phlegm (or coughed up
blood) were considered to have active TB. Previous studies have shown that the presence
of these typical symptoms is likely to have sensitivity and specificity of 65–70% and 55–75%
to detect TB, respectively [47].
2.2.2. Non-Communicable Diseases (NCDs)
A total of nine NCDs (angina, arthritis, asthma, diabetes, depression, edentulism,
hearing problem, schizophrenia, and visual impairment) were assessed in the WHS. Arthri-
tis, asthma, and diabetes were based on self-reported lifetime diagnosis. For angina, in
addition to a self-reported diagnosis, a symptom-based diagnosis based on the Rose ques-
tionnaire was used [50]. The participant was considered to have hearing problems if the
interviewer observed this condition at the end of the survey. Depression was defined
using the Diagnostic and Statistical Manual of Mental Disorders (4th Edition; DSM-IV)
algorithm and was based on duration and persistence of depressive symptoms in the past
12 months using the same algorithms as in previous WHS publications [51,52]. Edentulism
was defined as an affirmative response to the question “Have you lost all your natural
teeth?” Participants were asked whether they had ever been diagnosed with schizophrenia
or psychosis. Those who answered affirmatively were considered to have schizophrenia.
While this question did not refer specifically to schizophrenia, for the sake of brevity, we
use the term ‘schizophrenia’ throughout the text. Visual impairment was defined as having
extreme difficulty in seeing and recognizing a person that the participant knows across the
road (i.e., from a distance about 20 m) [53]. A validity study showed that this response
likely corresponds to WHO definitions of visual impairment (20/60 or 0.48 The logarithm
of the minimal angle of resolution, logMAR) [53]. We calculated the total number of these
NCDs while allowing for one missing variable in order to retain a larger sample size. TB
multimorbidity was defined as having TB with one or more NCDs [8].
2.2.3. Control Variables
The selection of the control variables was based on past literature and included age,
sex, highest education achieved (no formal education, primary education, secondary
or high school completed, or tertiary education completed), wealth, current smoking,
and heavy episodic drinking [8,54]. Country-wise wealth quintiles were created using
principal component analysis based on 15–20 assets including country-specific items for
some countries. Heavy episodic drinking was defined as having consumed ≥4 (female) or
≥5 (male) standard alcoholic beverages on ≥2 days in the past 7 days [55].
2.3. Statistical Analysis
Publicly available data of the WHS included 69 countries. The data were nationally
representative for all countries with the exception of China, Comoros, the Republic of
Congo, Ivory Coast, India, and Russia. We excluded 10 countries as they lacked sampling
information. A further 10 high-income countries were excluded as the focus of the study
was on LMICs. Finally, Turkey was excluded due to lack of information on education and
diabetes. Thus, a total of 48 countries, of which 21 (n = 105,286) and 27 (n = 137,666) were
low-income and middle-income countries, respectively, at the time of the survey (2003)
according to the World Bank classification, were included in the final sample. Information
on the individual countries is provided in Table A1.
The statistical analysis was performed with Stata 14.1 (Stata Corp LP, College station,
TX, USA). The difference in sample characteristics between those with and without TB was
tested by Chi-squared tests and Student’s t-tests for categorical and continuous variables,
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respectively. In patients with TB, tetrachoric correlations between each pair of NCDs and
the prevalence of their co-occurrence were calculated. We also estimated and compared
years lived with disability (YLDs) in both people with and without TB. YLDs were based
on the prevalence of and the disability weights [56] assigned to the nine NCDs and TB.
Limited by the cross-sectional data, we assumed that people lived in the same health status
for one year. Using the overall sample, the association of each NCD, and number of NCDs
(exposures) with TB (outcome) was assessed with multivariable logistic regression analysis.
The association between NCD multimorbidity and TB was also assessed by sex, age group,
and country-income level. All regression analyses were adjusted for age, sex, wealth,
education, smoking, heavy drinking, and country with the exception of the sex-stratified
analysis, which was not adjusted for sex. Adjustment for country was done by including
dummy variables in the models, as in previous WHS publications [48,57]. All variables
were included in the models as categorical variables with the exception of age (continuous
variable). In order to assess the influence of multicollinearity, we calculated the variance
inflation factor (VIF) value for each independent variable. The highest VIF was 1.43, which
is much lower than the commonly used cut-off of 10 [58], indicating that multicollinearity
was unlikely to be a problem in our analyses. The sample weighting and the complex study
design were taken into account in all analyses. Results from the logistic regression are
presented as odds ratios (ORs) with 95% confidence intervals (CIs). The level of statistical
significance was set at p < 0.05.
3. Results
The final sample consisted of 242,952 adults aged ≥18 years, mean (SD) age 38.4 (16.0)
years and 50.8% were female (Table 1). The overall prevalence of TB was 1.7%, while the
prevalence of TB multimorbidity (i.e., TB and at least one NCD) was 1.12%. The prevalence
of male sex, lower levels of wealth and education, smoking, and all NCDs as well as greater
number of NCDs was significantly higher among those with TB. The prevalence of TB
increased linearly with increasing number of NCDs (Figure A1). Specifically, the prevalence
was 0.8% among those with no NCDs but increased to 14.7% among those with ≥5 NCDs.
The associations between the individual NCDs and TB estimated by multivariable logistic
regression are shown in Figure 1. Except for visual impairment, all NCDs were significantly
associated with TB with particularly strong associations (i.e., OR ≥3) observed for asthma,
angina, and depression. In terms of the adjusted association between the number of NCDs
and TB, there was a linear increase in the ORs with increasing number of NCDs (Figure 2).
Specifically, compared to those with no NCDs, the OR for TB was 2.61, 4.71, 6.96, 10.59, and
19.89 for 1, 2, 3, 4, and ≥5 NCDs, respectively.
Table 1. Sample characteristics.
Tuberculosis
Characteristic Overall No Yes p-Value a
Age (years) Mean (SD) 38.4 (16.0) 35.5 (16.0) 43.4 (17.1) <0.001
Sex Male 49.2 49.1 54.0 0.010
Female 50.8 50.9 46.0
Wealth Poorest 20.5 20.3 31.7 <0.001
Poorer 20.0 19.9 22.6
Middle 20.0 20.0 17.7
Richer 19.8 19.9 16.6
Richest 19.8 19.9 11.4
Education No formal 25.2 24.9 43.9 <0.001
Primary 31.8 31.7 34.2
Secondary 33.1 33.4 19.4
Tertiary 9.9 10.0 2.5
Smoking No 72.8 72.9 63.0 <0.001
Yes 27.2 27.1 37.0
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Table 1. Cont.
Tuberculosis
Characteristic Overall No Yes p-Value a
Heavy drinking No 97.9 98.0 97.6 0.354
Yes 2.1 2.0 2.4
Angina No 85.4 85.8 60.3 <0.001
Yes 14.6 14.2 39.7
Arthritis No 87.1 87.3 74.5 <0.001
Yes 12.9 12.7 25.5
Asthma No 94.6 94.9 78.2 <0.001
Yes 5.4 5.1 21.8
Diabetes No 96.9 96.9 93.4 <0.001
Yes 3.1 3.1 6.6
Depression No 92.9 93.2 75.8 <0.001
Yes 7.1 6.8 24.2
Edentulism No 93.7 93.8 89.5 <0.001
Yes 6.3 6.2 10.5
Hearing problems No 96.5 96.6 91.6 <0.001
Yes 3.5 3.4 8.4
Schizophrenia No 98.9 99.0 95.5 <0.001
Yes 1.1 1.0 4.5
Visual impairment No 98.6 98.6 97.8 0.030
Yes 1.4 1.4 2.2
No. of NCD 0 65.6 65.6 31.2 <0.001
1 21.8 21.8 29.2
2 8.4 8.4 20.4
3 3.0 3.0 11.3
4 0.9 0.9 4.6
≥5 0.3 0.3 3.3
Abbreviation: SD Standard deviation; NCD Non-communicable disease. Data are % unless otherwise stated. a p-value
was based on Chi-squared tests for categorical variables and Student’s t-tests for continuous variables (age).
Figure 1. Association between non-communicable diseases and tuberculosis estimated. by multivariable
logistic regression. Abbreviation: NCD Non-communicable disease; OR Odds ratio; CI Confidence
interval. Models are adjusted for age, sex, wealth, education, smoking, heavy drinking, and country.
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Figure 2. Association between number of non-communicable diseases and tuberculosis, estimated
by multivariable logistic regression. Abbreviation: NCD Non-communicable disease; OR Odds ratio;
CI Confidence interval. Reference category is no non-communicable disease. Model is adjusted for
age, sex, wealth, education, smoking, heavy drinking, and country.
The prevalence of one or more of these NCDs was 68.8% in people with TB, and 34.4%
in people without TB. Among those with TB, the strongest correlations in terms of the
pairs of NCDs were observed for depression and schizophrenia, followed by arthritis and
angina (Figure 3). The most prevalent pairs of concurring NCDs among people with TB
were angina and depression (15.3%), followed by arthritis and asthma (14.6%), asthma
and angina (10.7%), and depression and arthritis (9.7%) (Figure 4). Figure 5 highlights that
a third of YLDs in people with TB could be attributable to NCDs including depression,
angina, schizophrenia, asthma, arthritis and diabetes. The YLDs attributable to NCDs were
three times higher in TB than the YLDs attributable to NCDs in participants without TB.
Moreover, in people with TB, just over 55% of total YLDs were in patients with 2 or more
NCDs, 24% in patients with one NCD and 21% in patients with no NCD.
Figure 3. Prevalence of each pair of non-communicable diseases among individuals with tuberculosis. Numbers are
presented as %.
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Figure 4. Tetrachoric correlations of non-communicable diseases among individuals with tuberculosis. * p < 0.05.
Figure 5. The cumulative total of years lived with disability in a cohort of people with and without tuberculosis.
4. Discussion
To the best of our knowledge, the current study is the first representative multinational
LMIC study to investigate patterns of NCDs and YLDs associated with TB multimorbidity.
Almost all NCDs were significantly associated with TB with high odds observed for angina,
asthma and depression (OR ≥ 3.0). Moreover, we found a concerning linear increase in
the odds of TB with increasing number of NCDs. Furthermore, our data found that YLDs
attributable to NCDs were three times higher in people with TB than in those without TB.
Given the high prevalence of TB and multimorbidity, our results shed important new light
on the importance of understanding and preventing NCD comorbidity in TB.
While our study consisted of a relatively young adult sample (mean age = 38.4), the
prevalence of any NCD multimorbidity in our sample was relatively high (i.e., 13%). Ad-
vancing age has been associated with a higher multimorbidity rate, given the development
process from most biological pathways to chronic health conditions can be long [34]. The
prevalence of multimorbidity can be as high as 72% in older adults [39]. Reis-Santos and
colleagues [27] discovered that people with TB aged 60 and over in Brazil were 44 times
more likely to develop TB multimorbidity than their younger counterparts.
Our results suggest that male sex, lower levels of wealth and education, smoking,
prevalence of NCDs and associated multimorbidity were significantly higher among people
with TB than those without a TB diagnosis. Our results are consistent with previous
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findings: male sex [26,59] and smoking [6,7,60] are two important risk factors for the
elevated incidence of TB, and it has also been suggested that people with low educational
attainment and poor income are at a higher risk of developing TB [61,62]. The cost of
healthcare is a particularly relevant factor in LMICs, where the high healthcare cost relating
to NCDs may lead to increased financial restraints and financial burden for accessing
preventive health programs and treatment in low-income households [63–65].
Our results showed that the odds for TB increased linearly with the number of NCDs,
and that people with TB also reported three times the amount of YLDs due to NCDs
compared to those without TB. This is important, considering that a report from 2004 [66]
did not report TB among the conditions impacting YLDs in LMICs, so more focus on
TB is recommended for future investigations. Our results on the coexistence of NCDs
and TB are not surprising, considering that both can impact the organisms on several
levels. There is some existing evidence of the role of NCDs in the development of TB in
the literature, but this has typically been limited to a single country, non-representative
samples or considered a single or limited number of NCDs at any one time. A study of a
Korean population, for example, has found that both NCD and their risk factors can be the
determinants for the levels of registered TB in the local population [67]. However, we need
to consider that the association between TB and NCDs might be bidirectional. For example,
diabetes (a risk factor for TB [68]), can affect TB treatment, and increase the chance of
relapse and fatality rate [13]. At the same time, infection due to TB could affect glucose
tolerance [69] or glycaemia, hence posing a risk for aggravation in diabetes [70,71]. In terms
of the association between depression and TB, while TB could worsen depression due to
its effect on quality of life [72] and social stigma [73], depression itself may also affect our
immune system [74] and be an actual risk factor for TB [75]. Depression can also further
aggravate TB, since it is a risk factor for lack of compliance in medical treatment [76], and
certain anti-depressants might interfere with anti-TB agents [77]. Furthermore, a study on
people with pulmonary TB has also reported that comorbidity with depression can lead to
multi-drug resistance [78], possibly due to factors such as non-compliance to treatment.
Given the cross-sectional nature of the World Health Survey, a full discussion of the causal
association and direction of the relationship between NCD and TB is beyond our scope.
Nevertheless, our results were sufficient to assess the extent of NCD multimorbidity in TB.
Our study also found that the most prevalent pairs of co-occurring NCDs in peo-
ple with TB were depression and angina, arthritis and angina, asthma and angina, and
depression and arthritis. Angina showed several interesting associations in terms of multi-
morbidity according to our results. There is evidence on how patients with early psoriatic
arthritis report higher rates of angina compared to the general population [79], while
the co-occurrence of angina and asthma seems to be common in males according to a
study by Cazzola and colleagues [80]. The association of depression with both angina
and arthritis could be due to the impact of such diseases on normal functioning. In fact,
there is evidence suggesting an association of angina symptoms with anxiety, depression,
and impaired physical functioning [81]. A meta-analysis by Matcham and colleagues [82]
reports a high prevalence of depression in rheumatoid arthritis, as well as an association
with poorer outcomes related to arthritis. Our findings have important implications in
informing policy change and clinical practice. The key message is that when managing TB
patients, due to the co-occurrence of TB with NCDs, some specific NCD multimorbidity
clusters (e.g., angina and depression) deserve early detection and specific care. Frequent
screening of NCDs should be provided in routine TB care. Furthermore, considering the
burden and frequency of the co-occurrence of depression with NCDs [83] and with TB [60],
our results suggest the need for a strategy for management that can take all these factors
into consideration. Finally, continuous education regarding the co-occurrence of TB and
specific NCDs or NCD multimorbidity for healthcare providers may lead to early detection
of TB multimorbidity and better patient care.
Altogether, our findings are consistent with the so called “syndemic theory”, which
addresses the co-occurring diseases that afflict low-income populations from multiple
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perspectives [84]. According to this model, co-occurring conditions share similar patho-
physiology, predisposed by biological factors, and affect people not only through somatic
symptoms, but also by undermining their daily activities and personal and social expe-
riences in society. All of this is influenced by structural and societal inequalities, which
could expose people to risk factors for certain comorbidities, and by cultural factors, which
could impact the response to illness and disabilities. Considering the syndemic perspec-
tive, our study provides further evidence on the co-occurrence of physical and mental
conditions, hence underlining the increasing need to address health inequalities in LMICs.
Multimorbidity comes with great symptom complexity which may influence time spent in
the hospital and healthcare costs [34]. This is concerning given that in LMICs, there is a
lack of an integrated health care system, high costs in accessing healthcare [85], and a need
to plan all levels of care with the consideration of economic burden [17]. A sustainable
healthcare education [3] and an integrated approach [34] should hence be recommended
for health staff in these areas.
Whilst our study has substantially contributed to advancing the field and includes
a representative multinational sample across 48 LMICs, some limitations should be con-
sidered. First, this study is cross-sectional in nature, hence, the causality and temporality
between TB and NCDs could not be inferred. Future research with a prospective cohort
design will provide rigorous evidence of the relationship between TB and NCDs. Second,
the utilization of self-reported measures for NCDs and mental health diagnoses may have
led to recall bias or underdiagnosis in our sample, especially in older subjects. On a similar
note, the diagnosis of TB was also based on self-reported typical symptoms; therefore,
there was also the possibility for misclassification. Whilst there are multiple other studies
that have been published using this data in other populations [11,17,21], this considera-
tion should be taken into account. Furthermore, distinction between drug-sensitive and
multidrug-resistant TB could not be addressed. Therefore, future studies should include
different types of TB and may wish to consider the inclusion of more objective diagnostic
methods for physical and mental health conditions, such as patients’ hospital medical
records. Third, our study included nine physical conditions but lacked information on
some other important NCDs such as chronic obstructive pulmonary disease (COPD) and
bronchiectasis. Therefore, the prevalence of multimorbidity could be higher if more condi-
tions were included. Fourth, the prevalence of diabetes was lower than recent population
prevalence figures in many of these countries [86], suggesting that the prevalence of di-
abetes in people with TB might have also gone up remarkably in recent years, or that
diabetes might have been under diagnosed before. Fifth, the LMICs included in the current
study were categorized based on the World Bank classification at the time of the survey
(2003). Therefore, the demographics and epidemiology of many included countries are
likely to have changed over the last 20 years. New surveys should be carried out and
provide the most up-to-date evidence in order to inform the relationship between TB and
NCDs in LMICs. Finally, our study did not include at-risk samples, such as homeless
individuals or prisoners. The prevalence of chronic health conditions (e.g., infections,
mental health problems) and subsequent all-cause mortality tends to be higher among
marginalized populations [87,88]. Future research should thus consider these vulnerable
and marginalized populations. Altogether, our results and limitations suggest the need
to further explore and address the co-occurrence of NCDs and TB considering different
epidemiologic, demographic, and symptomatic profiles, in order to better tailor prevention
and management strategies in those countries where the risk for such comorbidities is
higher, and the availability of resources is lower.
5. Conclusions
In summary, our data utilizing information from 48 LMICs suggests that TB is consis-
tently associated with multiple NCDs including key physical and mental health conditions.
Of concern, we identified that the YLDs were three times higher in people with TB versus
people without multimorbidity or TB. Clearly, there is an urgent need for further research
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to understand common clusters and develop effective interventions to prevent and treat
people with TB multimorbidity and reduce their associated impact in LMICs.
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Appendix A
Table A1. Countries included in the analysis.
Country Country-Income Level n
Bangladesh LIC 5942
Bosnia and Herzegovina MIC 1031
Brazil MIC 5000





Czech Republic MIC 949
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Table A1. Cont.

















South Africa MIC 2629








Abbreviation: LIC Low-income country; MIC Middle-income country.
Figure A1. Prevalence of tuberculosis by number of non-communicable diseases. Bars denote 95%
confidence intervals.
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